ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
35.71
-0.56%
US Tech 100
18,307.60
0.41%
S&P 500
5,307.01
-0.27%
US Dollar vs CAD
1.36874
-0.03%
Bitcoin
69,487.54
0.56%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Clearmind Medicine Inc (CMND)

  7. Clearmind Medicine Inc (CMND) News

CMND

Clearmind Medicine (CMND)

Clearmind Medicine Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:CMND
DateTimeSourceHeadlineSymbolCompany
05/10/20243:01PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CMNDClearmind Medicine Inc
05/10/20247:24AMGlobeNewswire Inc.Clearmind Medicine Advances its Proprietary Psychedelic- Based Synthetic Alcohol Beverage ProductNASDAQ:CMNDClearmind Medicine Inc
05/07/20243:01PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CMNDClearmind Medicine Inc
05/07/20246:46AMGlobeNewswire Inc.Clearmind Medicine Secures Exclusive Global Rights to Breakthrough Psychedelic Compounds for PTSD TreatmentNASDAQ:CMNDClearmind Medicine Inc
04/30/20243:15PMGlobeNewswire Inc.Clearmind Applies to Cease Being a Reporting Issuer in CanadaNASDAQ:CMNDClearmind Medicine Inc
04/17/20246:49AMGlobeNewswire Inc.Clearmind Medicine Announces Exclusive Licensing Agreement for Generation 3.0 Psychedelic Compounds for the Treatment of Mental DisordersNASDAQ:CMNDClearmind Medicine Inc
04/10/20246:17AMGlobeNewswire Inc.Clearmind Medicine Files U.S. Patent Application for Psychedelic-Based Treatment for Eating DisordersNASDAQ:CMNDClearmind Medicine Inc
04/09/20247:07AMGlobeNewswire Inc.Clearmind Medicine CEO Issues Letter to ShareholdersNASDAQ:CMNDClearmind Medicine Inc
03/19/20246:55AMGlobeNewswire Inc.Breakthrough in Wellness: Clearmind Medicine's Psychedelic Treatment Granted Divisional Patent Approval in ChinaNASDAQ:CMNDClearmind Medicine Inc
03/13/20247:14AMGlobeNewswire Inc.Clearmind Medicine Obtains Clearance for its Psychedelic- Based Alcoholism Clinical TrialNASDAQ:CMNDClearmind Medicine Inc
03/13/20246:30AMGlobeNewswire Inc.Clearmind Medicine Received Approval for a Voluntary Delisting of its Common Shares From the Canadian Securities ExchangeNASDAQ:CMNDClearmind Medicine Inc
02/27/20246:58AMGlobeNewswire Inc.Clearmind Medicine Submits Three Additional International Patent Applications for Innovative MDMA, Ibogaine and Ketamine CompoundsNASDAQ:CMNDClearmind Medicine Inc
02/27/20246:58AMGlobeNewswire Inc.SciSparc-Clearmind Partnership Yields Three New International Patent Applications for MDMA, Ibogaine and Ketamine CompoundsNASDAQ:CMNDClearmind Medicine Inc
02/23/20246:06AMGlobeNewswire Inc.Clearmind Medicine Receives Approval to Commence its Phase I/IIa Clinical Trial of CMND-100 for Alcohol Use DisorderNASDAQ:CMNDClearmind Medicine Inc
02/20/20246:14AMGlobeNewswire Inc.SciSparc and Clearmind Continue to Strengthen International Patent Portfolio with Next Generation Classic Psychedelic-Based CompoundsNASDAQ:CMNDClearmind Medicine Inc
02/20/20246:14AMGlobeNewswire Inc.Clearmind Medicine Submits Three International Patent Applications for Next Generation Classic Psychedelic-Based CompoundsNASDAQ:CMNDClearmind Medicine Inc
02/05/20246:51AMGlobeNewswire Inc.Clearmind Medicine Receives Patent Approval for its Psychedelic Based Treatment of Binge Behaviors in ChinaNASDAQ:CMNDClearmind Medicine Inc
02/01/20247:15AMGlobeNewswire Inc.Clearmind Medicine Announces Exclusive, Long-Term Licensing Agreement with Leading Israeli Research CenterNASDAQ:CMNDClearmind Medicine Inc
01/16/202410:19AMGlobeNewswire Inc.Clearmind Medicine Inc. Closes US$2.4 Million Registered Direct and Private PlacementNASDAQ:CMNDClearmind Medicine Inc
01/11/20248:28AMGlobeNewswire Inc.Clearmind Medicine Inc. Announces Pricing of $2.4 Million Registered Direct and Private PlacementNASDAQ:CMNDClearmind Medicine Inc
01/10/20246:18AMGlobeNewswire Inc.Clearmind Medicine Completed Type A Meeting with the FDANASDAQ:CMNDClearmind Medicine Inc
01/04/20246:18AMGlobeNewswire Inc.SciSparc and Clearmind Medicine Reflect on Successful Collaboration in 2023 Aiming to Upgrade Wide Range of Psychedelic-Based TreatmentsNASDAQ:CMNDClearmind Medicine Inc
01/04/20246:18AMGlobeNewswire Inc.Clearmind Medicine and SciSparc Reflect on Successful Collaboration in 2023 Aiming to Upgrade Wide Range of Psychedelic- Based TreatmentsNASDAQ:CMNDClearmind Medicine Inc
12/14/20237:26AMGlobeNewswire Inc.Clearmind Medicine Announces It Is In Compliance with All Applicable Nasdaq Listing StandardsNASDAQ:CMNDClearmind Medicine Inc
12/05/20237:47AMGlobeNewswire Inc.Clearmind Medicine Achieved Positive Results in Cocaine Addiction TreatmentNASDAQ:CMNDClearmind Medicine Inc
12/01/20237:14AMGlobeNewswire Inc.Weight loss MEAI: Clearmind Medicine’s Novel Obesity Drug Showed Positive Results in a Pre-Clinical TrialNASDAQ:CMNDClearmind Medicine Inc
11/28/20237:25AMGlobeNewswire Inc.Clearmind Medicine Announces Positive Results from its Weight Loss and Metabolic Disorder Program with its Proprietary Psychedelic- Based TreatmentNASDAQ:CMNDClearmind Medicine Inc
11/27/20237:55AMGlobeNewswire Inc.Clearmind Medicine to Participate in Traditional vs. Novel Psychedelics Virtual Event with Leading Industry FiguresNASDAQ:CMNDClearmind Medicine Inc
11/21/20237:15AMGlobeNewswire Inc.Clearmind Medicine Announces 1-for-30 Reverse Share SplitNASDAQ:CMNDClearmind Medicine Inc
11/17/20233:15PMGlobeNewswire Inc.Clearmind Medicine Announces Receipt of Nasdaq Delisting Notice and Plan for Immediate RecomplianceNASDAQ:CMNDClearmind Medicine Inc
 Showing the most relevant articles for your search:NASDAQ:CMND

Your Recent History

OKEX
VSYSUSDT
V SYSTEMS
CSE
AMQ
Abitibi Metals
COIN
CNNCUSD
NYSE
IACB
ION Acquisition Corp 2
LSE
RPF
LATK
SAC1BTC
Sable Coin
TSXV
EGM.H
OKEX
SBTCBTC
BIT
P1JO54
BNP Paribas Issuance BV
BIT
W75QL7
UBS
LATK
ROADUSDT
Yellow Road
USOTC
OCPNY
Olympus (PK)
COIN
NORTBTC
LSE
GASD
Boostnatgas
NYSE
BYM
BlackRock Municipal Inco...
TSXV
MU
Monster Uranium Corp.
Delayed Upgrade Clock
ADVFN Logo

Canada
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved